Compare Vanguard Short Term Corporate Bond ETF (VCSH) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vanguard Short Term Corporate Bond ETF vs 22nd Century Group Inc — how do they compare? Vanguard Short Term Corporate Bond ETF trades at $78.58, while 22nd Century Group Inc trades at $4.48 (market cap $1.49M). Which is the better fit depends on your goals.
| VCSH | XXII | |
|---|---|---|
Sector | Fixed Income | Technology |
52-Week High | $80.20 | $1.07K |
52-Week Low | $78.45 | $3.90 |
Market Cap | — | $1.49M |
Enterprise Value | — | -$6.74M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
VCSH trades at $78.64, down 0.1% on the day, with a bearish technical signal driven by moving averages. The ETF maintains a consistent dividend payout, with recent distributions of $0.29-$0.30 per share. News highlights institutional interest, such as Allspring Global Investments' 1.47 million share purchase in July 2026, while comparisons with peers like ISTB focus on yield and diversification.
The outlook remains cautious due to the bearish technical setup and potential interest rate volatility. Opportunities include the ETF's high yield and low expense ratio, but risks involve Fed policy uncertainty and competitive pressure from other short-term bond funds. Investor sentiment is mixed, balancing income appeal against macroeconomic headwinds.
XXII trades at $4.32, down 0.23% on the day, with neutral technical signals and bearish moving averages. The company shows significant financial challenges with negative profit margins (-65.76% net income margin) and declining revenue, though analyst sentiment remains positive with 75% buy ratings. Recent corporate actions include a 20:1 reverse stock split completed in June 2026, while expansion initiatives in California and New York aim to drive VLN brand growth.
The outlook remains speculative with high execution risk given persistent losses and negative ROE (-130.19%). Investment opportunity hinges on successful commercialization of reduced-nicotine products and FDA regulatory progress, but substantial financial deterioration and competitive pressures present significant downside risk for shareholders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Vanguard Short Term Corporate Bond ETF
VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.
Read more on VCSH →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
